A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
Saved in:
| Main Authors: | Toshiki Okazaki, MD, Takehiro Takahashi, MD, PhD, Riichiro Sugiura, MD, Ryoko Shimada-Omori, MD, PhD, Yoshihide Asano, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625003108 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01) -
Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
by: Nada Alghamdi, et al.
Published: (2025-01-01) -
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
by: Teppei Hagino, et al.
Published: (2024-12-01) -
Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight
by: Francesca Falcinelli, et al.
Published: (2025-04-01) -
Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature
by: Li B, et al.
Published: (2025-05-01)